Product Images Venclexta

Each carton of VENCLEXTA® contains 1 weekly wallet. The yellow wallet contains 14 tablets, each coated and containing 10 mg of venetoclax. This medication is to be kept out of the reach of children and stored below 86°F (0°C) in the original container. Dispense the accompanying medication guide to each patient. Please see the package insert for complete prescribing information. The medication is manufactured and marketed by AbbVie Inc. of North Chicago and marketed by Genentech USA, Inc. of South San Francisco. ©2022 AbbVie Inc. ©2022 Genentech, Inc. This product is produced in Singapore.*

The text has a mix of errors and random characters, making it difficult to understand the content. The text is not available.*

This is a pharmaceutical product called VENCLEXTA containing 100 mg per tablet. The product is packaged for prescription purpose and each carton contains one daily blister with one venetoclax 100 mg tablet. The medication should be kept out of reach of children and stored in a cool container at a temperature below 86°C. The manufacturer is not indicated, but it is stated that the product is a part of the Roche Group, and the pack is produced in Singapore. The text also includes a barcode and a product identification number.*

VENCLEXTA® is a prescription medicine used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have not received treatment before or after previous treatment with chemotherapy. The box contains a bottle of 26 tablets of venetoclax 100 mg each. The film-coated tablet comprises 105 mg of venetoclax. It is advised to keep it out of children's reach and to store it below 86 degrees Fahrenheit. The package insert should be read carefully before use.*